Company
LAVA Therapeutics NV (0001840748)
Standardized SEC financial data for LAVA Therapeutics NV — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001840748 · Pharmaceutical Preparations.
Gross margin
27.4%
Operating margin
-247.8%
Net margin
-209.6%
Revenue growth (YoY)
77.0%
Return on equity
-90.5%
ROIC
-937.5%
Free cash flow
-$19.6M
Debt / equity
0.35×
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $6.8M | $12.0M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $100.3M | $44.2M | — | $35.0M |
| Total current assets |
Cash flow
| USD | FY2023 | FY2024 |
|---|---|---|
| Operating cash flow | -$40.3M | -$19.5M |
| Capital expenditures | $731K | $23K |
| Free cash flow | -$41.0M | -$19.6M |
| Investing cash flow | -$17.6M |
Get 0001840748 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001840748/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001840748/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"